Close Menu

Mass General

NEW YORK (GenomeWeb News) – MolecularMD today said it has licensed a genetic marker for the development of diagnostic assays for non-small cell lung cancer.

NEW YORK (GenomeWeb News) – A pair of studies appearing online today in Neuron have unearthed new inherited recessive mutations that appear to either contribute to or cause autism spectrum disorder.

NEW YORK (GenomeWeb News) – Massachusetts General Hospital researchers have received a $5.4 million grant to use genome sequencing in studies aimed at discovering switches in Alzheimer's-linked genes and how these may be controlled by environmental factors.

Massachusetts General Hospital's Diagnostic Molecular Pathology Laboratory and Translational Research Laboratory are planning to implement next-generation sequencing for screening cancer patients.

NEW YORK (GenomeWeb News) – PerkinElmer today announced a collaboration with researchers at Massachusetts General Hospital for the development of a sequencing informatics system to profile genetic changes in tumors.

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

NEW YORK (GenomeWeb News) – Affymetrix today announced a deal with Massachusetts General Hospital to co-develop cancer biomarker tests using Affy's QuantiGene ViewRNA Assay platform.

NEW YORK (GenomeWeb News) – Quickly proliferating cancer cells are prone to an uptick in use of the amino acid glycine, a new Science study suggests.

Pages

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.